Robert Christopher Andrade - Net Worth and Insider Trading
Robert Christopher Andrade Net Worth
The estimated net worth of Robert Christopher Andrade is at least $2 Million dollars as of 2025-06-02. Robert Christopher Andrade is the Senior Officer of Fennec Pharmaceuticals Inc and owns about 182,297 shares of Fennec Pharmaceuticals Inc (TSX:FRX) stock worth over $2 Million. Details can be seen in Robert Christopher Andrade's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Christopher Andrade has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Christopher Andrade
Robert Christopher Andrade Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Christopher Andrade owns 1 companies in total, including Fennec Pharmaceuticals Inc (TSX:FRX) .
Click here to see the complete history of Robert Christopher Andrade’s form 4 insider trades.
Insider Ownership Summary of Robert Christopher Andrade
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:FRX | Fennec Pharmaceuticals Inc | 2024-11-18 | Senior Officer |
Robert Christopher Andrade Latest Holdings Summary
Robert Christopher Andrade currently owns a total of 1 stock. Robert Christopher Andrade owns 182,297 shares of Fennec Pharmaceuticals Inc (TSX:FRX) as of November 18, 2024, with a value of $2 Million.
Latest Holdings of Robert Christopher Andrade
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:FRX | Fennec Pharmaceuticals Inc | 2024-11-18 | 182,297 | 11.25 | 2,050,841 |
Holding Weightings of Robert Christopher Andrade
Robert Christopher Andrade Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Christopher Andrade has made a total of 13 transactions in Fennec Pharmaceuticals Inc (TSX:FRX) over the past 5 years, including 3 buys and 10 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the acquisition of 15,816 shares on November 18, 2024, which cost Robert Christopher Andrade around $53,307.
Insider Trading History of Robert Christopher Andrade
- 1
Robert Christopher Andrade Trading Performance
GuruFocus tracks the stock performance after each of Robert Christopher Andrade's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Christopher Andrade is 31.83%. GuruFocus also compares Robert Christopher Andrade's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Christopher Andrade within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Christopher Andrade's insider trading performs compared to the benchmark.
Performance of Robert Christopher Andrade
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.5 | | | | | |
| Relative Return to S&P 500(%) | 9.96 | | | | | |
Robert Christopher Andrade Ownership Network
Ownership Network List of Robert Christopher Andrade
Ownership Network Relation of Robert Christopher Andrade
Robert Christopher Andrade Owned Company Details
What does Fennec Pharmaceuticals Inc do?
Who are the key executives at Fennec Pharmaceuticals Inc?
Robert Christopher Andrade is the Senior Officer of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include Director & Senior Officer Jeffrey Hackman , Director & Senior Officer Rostislav Christov Raykov , and Senior Officer Adrian J. Haigh .
Fennec Pharmaceuticals Inc (TSX:FRX) Insider Trades Summary
Over the past 18 months, Robert Christopher Andrade made 3 insider transaction in Fennec Pharmaceuticals Inc (TSX:FRX) with a net sale of 12,134. Other recent insider transactions involving Fennec Pharmaceuticals Inc (TSX:FRX) include a net sale of 38,960 shares made by Rostislav Christov Raykov , a net sale of 0 shares made by Adrian J. Haigh , and a net purchase of 4,374 shares made by Chris Anigeron Rallis .
In summary, during the past 3 months, insiders sold 38,076 shares of Fennec Pharmaceuticals Inc (TSX:FRX) in total and bought 17,173 shares, with a net sale of 20,903 shares. During the past 18 months, 233,183 shares of Fennec Pharmaceuticals Inc (TSX:FRX) were sold and 201,463 shares were bought by its insiders, resulting in a net sale of 31,720 shares.
Fennec Pharmaceuticals Inc (TSX:FRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fennec Pharmaceuticals Inc Insider Transactions
Robert Christopher Andrade Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Christopher Andrade. Currently GuruFocus does not have mailing address information for Robert Christopher Andrade.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
